Jason Warren  Lilly net worth and biography

Jason Lilly Biography and Net Worth

VP of Neogen
A NEOGEN team member since 2005, Jason was appointed Vice President of International Business in 2019 after serving for many years as Vice President of Corporate Development, where he led more than 20 acquisitions on a global basis. In his current role, he leads the international NEOGEN teams responsible for global growth and customer success. Previously, he served various roles at NEOGEN.

What is Jason Warren Lilly's net worth?

The estimated net worth of Jason Warren Lilly is at least $403,032.08 as of October 13th, 2023. Dr. Lilly owns 26,744 shares of Neogen stock worth more than $403,032 as of March 19th. This net worth estimate does not reflect any other investments that Dr. Lilly may own. Learn More about Jason Warren Lilly's net worth.

How do I contact Jason Warren Lilly?

The corporate mailing address for Dr. Lilly and other Neogen executives is 620 LESHER PLACE, LANSING MI, 48912. Neogen can also be reached via phone at (517) 372-9200 and via email at [email protected]. Learn More on Jason Warren Lilly's contact information.

Has Jason Warren Lilly been buying or selling shares of Neogen?

Jason Warren Lilly has not been actively trading shares of Neogen during the last ninety days. Most recently, Jason Warren Lilly sold 351 shares of the business's stock in a transaction on Friday, October 13th. The shares were sold at an average price of $15.10, for a transaction totalling $5,300.10. Following the completion of the sale, the vice president now directly owns 26,744 shares of the company's stock, valued at $403,834.40. Learn More on Jason Warren Lilly's trading history.

Who are Neogen's active insiders?

Neogen's insider roster includes John Adent (CEO), William Boehm (Director), Ronald Green (Director), Douglas Jones (Insider), Jason Lilly (VP), Terri Morrical (Director), David Naemura (CFO), G. Papesh (Director), Steven Quinlan (CFO), James Tobin (Director), and Darci Vetter (Director). Learn More on Neogen's active insiders.

Are insiders buying or selling shares of Neogen?

In the last twelve months, Neogen insiders bought shares 3 times. They purchased a total of 22,000 shares worth more than $334,100.00. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 6,359 shares worth more than $109,708.34. The most recent insider tranaction occured on November, 3rd when Director William T Boehm bought 2,000 shares worth more than $32,100.00. Insiders at Neogen own 0.7% of the company. Learn More about insider trades at Neogen.

Information on this page was last updated on 11/3/2023.

Jason Warren Lilly Insider Trading History at Neogen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/13/2023Sell351$15.10$5,300.1026,744View SEC Filing Icon  
10/11/2023Sell1,917$15.69$30,077.7325,944View SEC Filing Icon  
12/23/2021Sell636$44.91$28,562.76View SEC Filing Icon  
9/30/2021Sell15,998$43.72$699,432.56View SEC Filing Icon  
4/13/2021Sell993$92.25$91,604.2510,353View SEC Filing Icon  
2/5/2021Sell2,265$85.23$193,045.9511,346View SEC Filing Icon  
1/6/2021Sell11,021$82.91$913,751.1118,032View SEC Filing Icon  
1/6/2021Sell11,021$82.91$913,751.1118,032View SEC Filing Icon  
10/21/2020Sell6,666$70.62$470,752.9217,075View SEC Filing Icon  
8/5/2020Sell5,681$80.08$454,934.4816,090View SEC Filing Icon  
5/5/2020Sell885$64.00$56,640.0010,409View SEC Filing Icon  
2/14/2020Sell7,107$72.75$517,034.2518,401View SEC Filing Icon  
11/21/2019Sell2,500$64.61$161,525.0012,901View SEC Filing Icon  
See Full Table

Jason Warren Lilly Buying and Selling Activity at Neogen

This chart shows Jason Warren Lilly's buying and selling at Neogen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neogen Company Overview

Neogen logo
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Read More

Today's Range

Now: $15.07
Low: $15.04
High: $15.27

50 Day Range

MA: $16.81
Low: $15.06
High: $19.84

2 Week Range

Now: $15.07
Low: $14.44
High: $24.09

Volume

1,287,266 shs

Average Volume

1,972,509 shs

Market Capitalization

$3.26 billion

P/E Ratio

251.21

Dividend Yield

N/A

Beta

1.14